These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30605634)

  • 1. Linking (Pyr)
    Onorato JM; Xu C; Chen XQ; Rose AV; Generaux C; Lentz K; Shipkova P; Arthur S; Hennan JK; Haskell R; Myers MC; Lawrence RM; Finlay HJ; Basso M; Bostwick J; Fernando G; Garcia R; Hellings S; Hsu MY; Zhang R; Zhao L; Gargalovic P
    Anal Biochem; 2019 Mar; 568():41-50. PubMed ID: 30605634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of an LC-MS/MS method for detection and quantification of in vivo derived metabolites of [Pyr
    Nyimanu D; Kay RG; Sulentic P; Kuc RE; Ambery P; Jermutus L; Reimann F; Gribble FM; Cheriyan J; Maguire JJ; Davenport AP
    Sci Rep; 2019 Dec; 9(1):19934. PubMed ID: 31882594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-Converting Enzyme 2 Metabolizes and Partially Inactivates Pyr-Apelin-13 and Apelin-17: Physiological Effects in the Cardiovascular System.
    Wang W; McKinnie SM; Farhan M; Paul M; McDonald T; McLean B; Llorens-Cortes C; Hazra S; Murray AG; Vederas JC; Oudit GY
    Hypertension; 2016 Aug; 68(2):365-77. PubMed ID: 27217402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of apelin on the cardiac hemodynamics in hypertensive rats with heart failure.
    Pang H; Han B; Yu T; Zong Z
    Int J Mol Med; 2014 Sep; 34(3):756-64. PubMed ID: 24993609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Outcomes of (Pyr
    Yamaleyeva LM; Brosnihan KB; Elsangeedy E; McGee C; Shi S; Caudell D; Miller C; Varagic J; Bader M; Dechend R; Shaltout HA
    Sci Rep; 2019 Jun; 9(1):8579. PubMed ID: 31189936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatography/tandem mass spectrometry assay for the absolute quantification of the expected circulating apelin peptides in human plasma.
    Mesmin C; Dubois M; Becher F; Fenaille F; Ezan E
    Rapid Commun Mass Spectrom; 2010 Oct; 24(19):2875-84. PubMed ID: 20857448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man.
    Katugampola SD; Maguire JJ; Matthewson SR; Davenport AP
    Br J Pharmacol; 2001 Mar; 132(6):1255-60. PubMed ID: 11250876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic administration of [Pyr
    Hajimashhadi Z; Aboutaleb N; Nasirinezhad F
    Neuropeptides; 2017 Feb; 61():15-22. PubMed ID: 27686494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of 6-hydroxy-5-phenyl sulfonylpyrimidin-4(1H)-one APJ receptor agonists.
    Tora G; Jiang J; Bostwick JS; Gargalovic PS; Onorato JM; Luk CE; Generaux C; Xu C; Galella MA; Wang T; He Y; Wexler RR; Finlay HJ
    Bioorg Med Chem Lett; 2021 Oct; 50():128325. PubMed ID: 34403724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability and degradation patterns of chemically modified analogs of apelin-13 in plasma and cerebrospinal fluid.
    Murza A; Belleville K; Longpré JM; Sarret P; Marsault É
    Biopolymers; 2014 Jul; 102(4):297-303. PubMed ID: 24728860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apelin peptides linked to anti-serum albumin domain antibodies retain affinity in vitro and are efficacious receptor agonists in vivo.
    Read C; Yang P; Kuc RE; Nyimanu D; Williams TL; Glen RC; Holt LJ; Arulanantham H; Smart A; Davenport AP; Maguire JJ
    Basic Clin Pharmacol Toxicol; 2020 Jun; 126 Suppl 6():96-103. PubMed ID: 30901161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats.
    Azizi Y; Faghihi M; Imani A; Roghani M; Zekri A; Mobasheri MB; Rastgar T; Moghimian M
    Eur J Pharmacol; 2015 Aug; 761():101-8. PubMed ID: 25936512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On Methods for the Measurement of the Apelin Receptor Ligand Apelin.
    Janssens P; de Loor H; Decuypere JP; Vennekens R; Llorens-Cortes C; Mekahli D; Bammens B
    Sci Rep; 2022 May; 12(1):7763. PubMed ID: 35546171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease.
    Maguire JJ; Kleinz MJ; Pitkin SL; Davenport AP
    Hypertension; 2009 Sep; 54(3):598-604. PubMed ID: 19597036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pyr
    Yang P; Kuc RE; Brame AL; Dyson A; Singer M; Glen RC; Cheriyan J; Wilkinson IB; Davenport AP; Maguire JJ
    Front Neurosci; 2017; 11():92. PubMed ID: 28293165
    [No Abstract]   [Full Text] [Related]  

  • 16. Pyroglutamyl apelin-13 identified as the major apelin isoform in human plasma.
    Zhen EY; Higgs RE; Gutierrez JA
    Anal Biochem; 2013 Nov; 442(1):1-9. PubMed ID: 23872001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolyl Carboxypeptidase Mediates the C-Terminal Cleavage of (Pyr)-Apelin-13 in Human Umbilical Vein and Aortic Endothelial Cells.
    De Hert E; Bracke A; Pintelon I; Janssens E; Lambeir AM; Van Der Veken P; De Meester I
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Systematic Exploration of Macrocyclization in Apelin-13: Impact on Binding, Signaling, Stability, and Cardiovascular Effects.
    Trân K; Murza A; Sainsily X; Coquerel D; Côté J; Belleville K; Haroune L; Longpré JM; Dumaine R; Salvail D; Lesur O; Auger-Messier M; Sarret P; Marsault É
    J Med Chem; 2018 Mar; 61(6):2266-2277. PubMed ID: 29461833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypotensive effect of activated apelin receptor is correlated with β-arrestin recruitment.
    Besserer-Offroy É; Bérubé P; Côté J; Murza A; Longpré JM; Dumaine R; Lesur O; Auger-Messier M; Leduc R; Marsault É; Sarret P
    Pharmacol Res; 2018 May; 131():7-16. PubMed ID: 29530600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective effect of apelin-13 on cardiac performance and remodeling in end-stage heart failure.
    Koguchi W; Kobayashi N; Takeshima H; Ishikawa M; Sugiyama F; Ishimitsu T
    Circ J; 2012; 76(1):137-44. PubMed ID: 22082814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.